MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$329,029K
EPS
-$538.96
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Net unrealized gains (losses) on marketable securities
-92
Total other comprehensive income (loss)
-92
Research and development
269,780
General and administrative
63,583
Total operating expenses
333,363
Loss from operations
-333,363
Change in fair value of cvr liability
0
Interest income
14,689
Interest expense
3,062
Loss on debt extinguishment
-7,181
Other income (expense), net
-20
Total other income, net
4,426
Net loss
-328,937
Comprehensive loss
-329,029
Basic EPS
-538.96
Diluted EPS
-538.96
Basic Average Shares
67,600
Diluted Average Shares
67,600
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$329,029K Interest income$14,689K Net loss-$328,937K Total othercomprehensive income (loss)-$92K Total other income,net$4,426K Loss on debtextinguishment-$7,181K Interest expense$3,062K Other income(expense), net-$20K Loss from operations-$333,363K Net unrealizedgains (losses) on...-$92K Total operatingexpenses$333,363K Research and development$269,780K General andadministrative$63,583K

Cogent Biosciences, Inc. (COGT)

Cogent Biosciences, Inc. (COGT)